Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement
September 30, 2024 11:29 ET
|
American College of Medical Toxicology
Phoenix, AZ, Sept. 30, 2024 (GLOBE NEWSWIRE) -- In May of 2024, Louisiana enacted a law classifying mifepristone and misoprostol as Schedule IV controlled dangerous substances, akin to medications...
CDC Announces National Partners Cooperative Agreement Recipients: American College of Medical Toxicology Among Awardees
September 27, 2024 11:47 ET
|
American College of Medical Toxicology
Phoenix, AZ, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The American College of Medical Toxicology (ACMT) is pleased to announce it has been named a recipient of a new five-year cooperative agreement with...
Opioid Overdose Cases Show Presence of Medetomidine, Veterinary Medicine Similar to Xylazine, According to Recent Study by the Toxicology Investigators Consortium
August 01, 2024 14:16 ET
|
American College of Medical Toxicology
Phoenix, AZ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Data gathered by the Toxicology Investigators Consortium (ToxIC) Fentalog Study was reported in the CDC’s August 1, 2024 Morbidity and Mortality Weekly...
NIDA Director to Deliver Keynote; Innovative Toxicology Research to Feature at 2024 ACMT Annual Scientific Meeting and Symposia in Washington, DC
January 17, 2024 11:18 ET
|
American College of Medical Toxicology
Phoenix, AZ, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The American College of Medical Toxicology is pleased to announce the 2024 ACMT Annual Scientific Meeting (ASM) and Symposia taking place April 10 - 14...
Opioid and Stimulant Overdose Reporting Program to Expand Under Increased Federal Funding
October 17, 2023 12:45 ET
|
American College of Medical Toxicology
Phoenix, AZ, Oct. 17, 2023 (GLOBE NEWSWIRE) -- In September of 2022, the FDA awarded the American College of Medical Toxicology’s (ACMT) Toxicology Investigators Consortium (ToxIC) a 5-year $7.9...
Fentanyl, Xylazine, Cannabinoids to Feature in Virtual Forensic Toxicology Seminar December 14 - 15, 2023
October 16, 2023 10:00 ET
|
American College of Medical Toxicology
Phoenix, AZ, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The American College of Medical Toxicology (ACMT) and the Center for Forensic Science Research and Education (CFSRE) are pleased to offer a two-day...
Out-of-Hospital Naloxone Administration to be Studied in New Federally-Funded Project
October 02, 2023 11:31 ET
|
American College of Medical Toxicology
Phoenix, AZ, Oct. 02, 2023 (GLOBE NEWSWIRE) -- In September 2023, the FDA awarded the American College of Medical Toxicology’s (ACMT) Toxicology Investigators Consortium (ToxIC) through its Broad...
CDC Launches Fentanyl Dashboard Utilizing Data from the Toxicology Investigators Consortium (ToxIC) to Monitor Nonfatal Overdose Trends
June 09, 2023 12:54 ET
|
American College of Medical Toxicology
Phoenix, AZ, June 09, 2023 (GLOBE NEWSWIRE) -- Fentanyl, a powerful synthetic opioid, has emerged as a significant public health concern across the United States, contributing to a surge in...
Symposium to Address Suicidality, Bridging Toxicology and Mental Health
December 09, 2022 10:23 ET
|
American College of Medical Toxicology
Phoenix, AZ, Dec. 09, 2022 (GLOBE NEWSWIRE) -- After a 2-year hiatus from in-person activities, The American College of Medical Toxicology (ACMT) is pleased to present a full-day symposium exploring...
X Waiver Mini-Course Expands Emergency Clinician Recognition and Treatment of Opioid Withdrawal, Study Finds
April 13, 2022 08:00 ET
|
American College of Medical Toxicology
Phoenix, AZ, April 13, 2022 (GLOBE NEWSWIRE) -- “A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD)” was a study funded by a grant to the...